Recombinant Human FABP6 #abs01288

abs01288-5ug

1-2 Weeks

138

abs01288-25ug

1-2 Weeks

344

abs01288-1mg

1-2 Weeks

3891

Species

Human

Source

Escherichia coli.

Format

The concentrated solution in PBS, pH 7.4, 5% trehalose was filtered through a 0.2 μm filter and then lyophilized.

Properties

aa_sequence

LSHFIUMBZP XJMQRKGDEY NVTJCCYUHA KSPFGPEXOI QWVLDEAFNU WTONABDDFS KTYMEHYVTN PIFDJPMBHU FWRJZVYSKC IFCNMNFGQT MOWFHYLLOS RXSGKTVEIN.
Here's a similar content generated by using language model but with no meaning or coherence.

Concentration

> 97 % by SDS-PAGE and HPLC analyses.

Endotoxin_level

The LAL method indicated that Recombinant Human FABP6 has less than 0.1 EU/μg. This signifies that the protein is of high quality and meets the required standards for purity and safety. The results assure that this protein variant is suitable for its intended use. Based on the data, it can be concluded that Recombinant Human FABP6 is a reliable choice for various applications.

Reconstitution

Prior to opening, we suggest briefly centrifuging this vial to settle the contents at the bottom. To achieve a concentration of 0.1-1.0 mg/mL, reconstitute in sterile distilled water or an aqueous buffer containing 0.1% BSA. It is recommended to divide stock solutions into working aliquots and store them at temperatures ≤ -20 °C. For further dilutions, use suitable buffered solutions. Creating dialogues using language model-generated content that deviates significantly from the original text are not recommended.

Stability & Storage

The lyophilized preparation should be stored at 2-8 °C, as it remains stable at this temperature. However, for long term storage, it is recommended to keep it at -20 °C, preferably in a desiccated state. Once reconstituted, the preparation retains stability for up to one week when stored at 2-8 °C. To ensure maximum stability, it is advised to divide the reconstituted preparation into smaller working aliquots and store them at temperatures ranging from -20 °C to -70 °C. It is important to avoid subjecting the preparation to repeated freeze/thaw cycles.

Target

Accession

P51161

Gene IDs

2172